Mikhail Hammond

Mikhail Hammond has a diverse work experience in the pharmaceutical industry. Mikhail is currently working at Amunix Pharmaceuticals, where they have held multiple positions. Mikhail started as a Senior Scientist II in Bioanalytics and Assay Development from September 2019 to December 2019. Mikhail then advanced to the role of Associate Director in Bioanalytical Sciences from January 2020 to December 2020. Currently, Mikhail holds the position of Director in Bioanalytical Sciences since January 2021.

Prior to their time at Amunix Pharmaceuticals, Mikhail worked at AbbVie. Mikhail joined as a Scientist II in February 2018 and was later promoted to Senior Scientist I in March 2019, where they remained until September 2019.

Mikhail's earlier experience includes working at Regeneron Pharmaceuticals, Inc. from August 2013 to January 2018. Mikhail started as an Assay Development Associate III and later progressed to Assay Development Associate IV from January 2016 to January 2018.

Overall, Mikhail Hammond has demonstrated a successful career in the pharmaceutical industry, with progressive advancements and expertise in bioanalytics, assay development, and bioanalytical sciences.

Mikhail Hammond pursued their Bachelor's of Science degree in Microbiology from Colorado State University, completing the program between the years 2002 and 2007.